IL17A and Alzheimer disease: Gene expression of the acute and chronic AD-related IL-1β, IL-6, and TNF-α as well as Th9-, Th17-, Th22-related IL-9, IL-17, and IL-22, respectively, was significantly increased in the control group compared to levels in the normal group.